Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Harama D"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł :
IMiDs uniquely synergize with TKIs to upregulate apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells expressing a dominant-negative IKZF1 isoform.
Autorzy :
Harama D; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Yahata T; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Kagami K; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Abe M; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Ando N; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Kasai S; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Tamai M; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Akahane K; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Inukai T; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Kiyokawa N; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
Ibrahim AA; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Ando K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Sugita K; Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan. .
Pokaż więcej
Źródło :
Cell death discovery [Cell Death Discov] 2021 Jun 11; Vol. 7 (1), pp. 139. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell lines.
Autorzy :
Akahane K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Yasuda T; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Tsuzuki S; Department of Biochemistry, Aichi Medical University, Nagakute, Japan.
Hayakawa F; Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kiyokawa N; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
Somazu S; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Watanabe A; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Kagami K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Abe M; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Harama D; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Goi K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Kawazu M; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
Kojima S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Goto H; Department of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Iwamoto S; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
Minegishi M; Japanese Red Cross Miyagi Blood Center, Sendai, Japan.
Abe M; Professor Emeritus, Fukushima Medical University, Fukushima, Japan.
Hojo H; Department of Clinical Medicine Diagnostic Pathology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Japan.
Inaba T; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Mano H; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
Sugita K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2020 Oct; Vol. 38 (4), pp. 614-617. Date of Electronic Publication: 2020 Jun 24.
Typ publikacji :
Letter
MeSH Terms :
Oncogene Proteins, Fusion*/genetics
Oncogene Proteins, Fusion*/metabolism
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Cell Line, Tumor ; Humans ; MEF2 Transcription Factors/genetics ; MEF2 Transcription Factors/metabolism
Opinia redakcyjna
Tytuł :
Association of relapse-linked ARID5B single nucleotide polymorphisms with drug resistance in B-cell precursor acute lymphoblastic leukemia cell lines.
Autorzy :
Tamai M; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Huang M; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Kagami K; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Abe M; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Somazu S; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Shinohara T; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Harama D; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Watanabe A; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Akahane K; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Goi K; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.
Sugita K; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan.; Yamanashi Red Cross Blood Center, Kofu, Japan.
Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Minegishi M; Tohoku Block Center, Japanese Red Cross Society, Sendai, Japan.
Iwamoto S; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, 1110, Japan. .
Pokaż więcej
Źródło :
Cancer cell international [Cancer Cell Int] 2020 Sep 04; Vol. 20 (1), pp. 434. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies